You are welcome.
I believe ACAS was simply hit with that drop as were so many other companies in the Financial Sector Area, with the economic conditions, the Eurozone debt problems, and general negative perception, it has been somewhat of a roller coaster in that sector. I do believe we're past the worst. Considering the buyback of shares on their part and my continued confidence in their management team, I would expect the divvy to be reinstated.
Have been in and out, mostly in, with ACAS for about ten years.
My first buy years ago was at about $ 21 per share. My best buy was at $ 0.77 in their darkest hour.
Had DNDN years ago also, but unfortunately during my pursuit of Biotechs and Pharma back then, I managed to get kicked in the shins a few times.
My only Biotech that I am still holding now is ELN, but again it's because of the same familiarity with it that I have had with ACAS over the many years. I bought ELN in the $ 3 to $ 9 range and sold out in the high $20's but reentered when it was beaten back down. At the present share price, I do believe it's a good deal still, but it's just a somewhat steady but also somewhat slow movement up in the share price.
Am simply holding both at this time and really not worrying about either one since I am planning on holding them for the next few years.
Still have a few " Pennies ", strictly in the junior mining arena
........although my patience has been sorely tested on numerous occasions.....and I am a most patient sort of cuss.
News 
Market Data 
Discover 
